Evidence map›Paper›PMID 22595668›Full record

ArticleDevelopmental cell2012

FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program.

Andreia Ionescu, Elena Kozhemyakina, Claudia Nicolae, Klaus H Kaestner, Bjorn R Olsen, Andrew B Lassar

Open access · bronzeAbstract read
In one paragraph

Article in Developmental cell, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 56 papers.

0numbers the graph read from it
0cells of the map it votes in
56citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

56 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Downregulation of Nesprin1 by Runx2 deficiency is critical for the development of skeletal laminopathy-like pathology.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  4. Article
  5. Article
  6. Modeling of skeletal development and diseases using human pluripotent stem cells.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2024
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Stat5a promotesAmerican journal of translational research · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Andreia IonescuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA 02115, USA.
Elena Kozhemyakina
Claudia Nicolae
Klaus H Kaestner
Bjorn R Olsen
Andrew B Lassar
Harvard University · USUniversity of Pennsylvania · US

Funding

ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENTP01DK049210 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI AHIMA, REXFORD S. · 1995 to 2016
$26.9M
STRUCTURE OF TYPE I AND TYPE II PROCOLLAGENSR01AR036819 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI OLSEN, BJORN REINO · 1986 to 2016
$8.7M
COLLAGEN GENE STRUCTURE AND EXPRESSIONR01AR036820 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI OLSEN, BJORN REINO · 1986 to 2013
$6.7M
Identification of the transcriptional regulators of chondrocyte hypertrophyR01AR055552 · NIAMS · HARVARD MEDICAL SCHOOL · PI LASSAR, ANDREW BRUCE · 2010 to 2014
$1.8M
Regulation of chondrogenesisR01AR048524 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI LASSAR, ANDREW BRUCE · 2003 to 2007
$1.5M
BIOGENESIS OF EXTRACELLULAR MATRIXR37AR036819 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI OLSEN, BJORN R · 1992 to 2001
$827k
Biogenesis of Extracellular MatrixR56AR036819 · NIAMS · HARVARD MEDICAL SCHOOL · PI OLSEN, BJORN REINO · 2018 to 2019
$746k
COLLAGEN GENE STRUCTURE AND EXPRESSIONR37AR036820 · NIAMS · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI OLSEN, BJORN R · 1993 to 1995
–
NIAMS NIH HHS AR048524NIAMS NIH HHS AR055552NIAMS NIH HHS AR36819NIAMS NIH HHS AR36820NIAMS NIH HHS R01 AR036819NIAMS NIH HHS R01 AR036820NIAMS NIH HHS R01 AR048524NIAMS NIH HHS R01 AR055552NIAMS NIH HHS R37 AR036819NIAMS NIH HHS R56 AR036819NIDDK NIH HHS DK049210NIDDK NIH HHS DK054342NIDDK NIH HHS P01 DK049210
6 · The paper itself

Abstract

During endochondral ossification, small, immature chondrocytes enlarge to form hypertrophic chondrocytes, which express collagen X. In this work, we demonstrate that FoxA factors are induced during chondrogenesis, bind to conserved binding sites in the collagen X enhancer, and can promote the expression of a collagen X-luciferase reporter in both chondrocytes and fibroblasts. In addition, we demonstrate by both gain- and loss-of-function analyses that FoxA factors play a crucial role in driving the expression of both endogenous collagen X and other hypertrophic chondrocyte-specific genes. Mice engineered to lack expression of both FoxA2 and FoxA3 in their chondrocytes display defects in chondrocyte hypertrophy, alkaline phosphatase expression, and mineralization in their sternebrae and, in addition, exhibit postnatal dwarfism that is coupled to significantly decreased expression of both collagen X and MMP13 in their growth plates. Our findings indicate that FoxA family members are crucial regulators of the hypertrophic chondrocyte differentiation program.

Indexed as

Cell EnlargementAlkaline PhosphataseAnimalsBinding SitesCell DifferentiationCells, CulturedChick EmbryoChondrocytesChondrogenesisCollagen Type XCore Binding Factor Alpha 1 SubunitDwarfismEmbryo, MammalianFibroblastsGenes, ReporterGrowth PlateAlkaline PhosphataseCollagen Type XCore Binding Factor Alpha 1 SubunitFoxa2 protein, mouseFoxa3 protein, mouseHepatocyte Nuclear Factor 3-betaHepatocyte Nuclear Factor 3-gammaMatrix Metalloproteinase 13Mmp13 protein, mouseMyogenic Regulatory FactorsSmad1 Protein

Identifiers

PMID22595668
PMCPMC3356573
OpenAlexW2011498576

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.